DHP Korea

Is the very first pharmaceutical company specialized in single-dose
preservative-free ophthalmic products in South Korea.
We are committing the best of ourselves to research and
development of safer ophthalmic solutions by introducing
preservative-free technology to a number of ophthalmic
products of various types to treat dry eye syndrome,
conjunctivitis, infections and glaucoma etc.

Central laboratory in DHP Korea is developing new products of improved formulation through studies specializing in ophthalmic
products and devoted to development of innovative medicinal products, particularly focusing new drugs and combination
formulations. In addition, having a ‘Global Open Innovation’ mindset, we are continuing our best efforts to study new drugs
and to make it competitive by dosing so in order for advancing to global markets.